Lars Prestegarden

Holberg Fondsforvaltning AS (HF) is the wholly-owned fund management subsidiary of Norway-based Holberg Forvaltning AS, a holding company in which the founding partners are significant shareholders. Founded in 2000 by Gunnar J. Torgersen, Monica Mjøs Lassen, Inga Lise Lien Moldestad and Hogne I. Tyssøy, the firm is headquartered in Bergen and manages equity and fixed-income funds for individual and institutional investors.

Klaveness Ship Holding AS engages in the provision of shipping services. It operates through the Combination Carriers and Container segments. The Combination Carriers segment transports both dry cargo and caustic soda in the Far East, the Middle East, Australia, Brazil, and North America. The Container segment owns and operates a fleet of eight geared container vessels in the feeder segment. The company was founded on May 30, 2005 and is headquartered in Oslo, Norway.

SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Torvald Klaveness is a shipping Norwegian company that is focused on safety and uses data to improve the nature of shipping. The private company is based in Oslo, Norway. and has subsidiaries in Singapore. The CEOs of the company are Lasse Kristoffersen, Ernst André Meyer.

Klaveness Chartering AS engages in shipping, brokerage, and trading. The company was founded on December 12, 1967 and is headquartered in Oslo, Norway.

Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway.

Curida AS engages in the production of pharmaceutical products for other pharmaceutical companies, both in Norway and abroad. It manufactures and markets nasal and inhalation drug products. The company was founded in 1974 and is headquartered in Elverum, Norway.

Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway.

Part of Storebrand ASA, SKAGEN AS is a Norwegian fund management company. The company is based in Stavanger, Norway. SKAGEN was founded by Kristoffer Stensrud, Geir Tjetland, Åge Kristiansen Westbø, Tor Dagfinn Veen. Timothy Warrington has been the CEO of the company since 2007.